MedWorm: Pharmaceuticals

CEO Brondeau buys $1M in FMC stock

bizjournals.com Health Care:Pharmaceuticals headlines — Tue, 09 Feb 2010 14:54:20 +0100

The president and CEO of FMC Corp. bought $1 million of the chemical company’s stock. (FMC) (Source: bizjournals.com Health Care:Pharmaceuticals headlines)

MedWorm Message: Get the very latest Swine Flu news via the MedWorm Swine Flu RSS news feed - updated hourly from thousands of authoritative health and news sources.

Rand dipped in 4Q

bizjournals.com Health Care:Pharmaceuticals headlines — Tue, 09 Feb 2010 14:51:32 +0100

Buffalo business development company Rand Capital Corp. issued a fourth quarter financial report which showed the net asset value of its shares fell 2 cents to $3.40. (RAND) (Source: bizjournals.com Health Care:Pharmaceuticals headlines)

Bark Group Inc.: Bark Group Inc. Signs LOI to Acquire 10% Stake in Research Company Mindmetic

Market Wire - Pharmaceuticals and Biotech — Tue, 09 Feb 2010 14:51:00 +0100

NEW YORK, NY (MARKET WIRE) Bark Group Inc. (OTCBB: BKPG), a U.S. company with a multinational client base, announced today that the Company has signed a Letter of Intent to acquire a 10% stake in Mindmetic, a brain research company that develops neuromarketing research methods. (Source: Market Wire - Pharmaceuticals and Biotech)

Miraculins Inc.: Miraculins Announces Private Placement Offering

Market Wire - Pharmaceuticals and Biotech — Tue, 09 Feb 2010 14:50:00 +0100

WINNIPEG, MANITOBA (MARKET WIRE) Miraculins Inc. (TSX VENTURE: MOM), a medical diagnostic company focused on developing and commercializing diagnostic tests for unmet clinical needs, today announces a non-brokered private placement offering (the "Offering") of up to 7,150,000 units ("Units") at a price of $0.07 per Unit for gross proceeds of up to $500,500. Each Unit will be comprised of one common share of the Company (a "Share") and one Share purchase warrant (a "Warrant"). Each Warrant will entitle the holder to purchase one Share at a price of $0.10 per Share for a period of 12 months from the date the Warrant is issued. (Source: Market Wire - Pharmaceuticals and Biotech)

S3 Investment Company: S3 Investment Company Comments on Additional Contracts Valued at Over $57 Million Announced by Redwood Capital Client

Market Wire - Pharmaceuticals and Biotech — Tue, 09 Feb 2010 14:44:00 +0100

DANVILLE, CA (MARKET WIRE) S3 Investment Company, Inc. (PINKSHEETS: SIVC) today commented on three new construction contracts valued at over $57 million announced by a client of its Redwood Capital subsidiary. The new contracts were announced by Boyuan Construction Group, which is publicly traded on Canada's TSX Venture Exchange under the symbol BOY, and include two projects in Shandong province and one on Hainan Island, China. Redwood Capital, as part of the compensation it received as the Chinese merchant banking advisor for Boyuan Construction Group when it became listed on Canada's TSX Venture Exchange, received (Source: Market Wire - Pharmaceuticals and Biotech)

Plantiva: Aaaaachooo! Pollen Doesn't Have to Get You Down This Spring... Plantiva(R) Announces the Launch of a Breakthrough, Clinically-Tested Natural Health Product: AllerDX(R) for Environmental Sensitivities

Market Wire - Pharmaceuticals and Biotech — Tue, 09 Feb 2010 14:30:00 +0100

BOULDER, CO (MARKET WIRE) Plantiva announces the launch and immediate availability of the first natural product to clinically demonstrate that it restores breathing in less than 20 minutes. AllerDX is the first product to deliver significant scientifically proven results in an all-natural formula. (Source: Market Wire - Pharmaceuticals and Biotech)

MedWorm Message: Get the very latest Swine Flu news via the MedWorm Swine Flu RSS news feed - updated hourly from thousands of authoritative health and news sources.

EV Energy Partners prices public offering

bizjournals.com Health Care:Pharmaceuticals headlines — Tue, 09 Feb 2010 14:16:53 +0100

EV Energy Partners LP has priced a public offering of 3 million shares at $28.08 a share. (EVEP) (Source: bizjournals.com Health Care:Pharmaceuticals headlines)

Cutting Edge Information: Cutting Edge Information's Research to Be Presented at CBI's Second Annual Bio/Pharmaceutical and Medical Device Forum on Speaker Program Management

Market Wire - Pharmaceuticals and Biotech — Tue, 09 Feb 2010 14:12:00 +0100

RESEARCH TRIANGLE PARK, NC (MARKET WIRE) Senior Research Analyst Jordan Stone will present key findings from Cutting Edge Information's recent study "Pharmaceutical Speaker Programs: Measuring ROI and Communicating Value" at the Center for Business Intelligence's (CBI) Second Annual Bio/Pharmaceutical and Medical Device Forum on Speaker Program Management. For more details about the study, visit http://www.cuttingedgeinfo.com/pharma-speaker-programs/. (Source: Market Wire - Pharmaceuticals and Biotech)

Nabi Biopharmaceuticals Announces Mailing of Definitive Proxy Statement

Medical News (via PRIMEZONE) — Tue, 09 Feb 2010 14:03:00 +0100

ROCKVILLE, Md., Feb. 9, 2010 (GLOBE NEWSWIRE) -- Nabi Biopharmaceuticals (Nasdaq:NABI) (the "Company") announced today that it has commenced mailing its definitive proxy statement to stockholders for approval of the exclusive option and license agreement ("the NicVAX agreement") between the Company and GlaxoSmithKline Biologicals S.A. dated as of November 13, 2009 and the transactions contemplated thereby. The Company has scheduled a special meeting of stockholders for Tuesday, March 2, 2010 at 10:00 a.m. (EST) at the Bethesda Marriott, 5151 Pooks Hill Road in Bethesda, Maryland, to consider and vote on the NicVAX agreement and the transactions contemplated thereby. Stockholders of record as of the close of business on January 25, 2010 will be entitled to vote at the special meeting. (Sour...

Liberty Analytics Co. Initiates Independent Research Coverage on NexMed, Inc.

Medical News (via PRIMEZONE) — Tue, 09 Feb 2010 14:00:00 +0100

CALGARY, Alberta, Feb. 9, 2010 (GLOBE NEWSWIRE) -- Liberty Analytics Co., a leading provider of large, small - and micro-cap independent investment research, today initiated coverage on NexMed, Inc. (Nasdaq:NEXM). (Source: Medical News (via PRIMEZONE))

Lithera Successfully Completes Phase I Clinical Trial of LIPO-102

Medical News (via PRIMEZONE) — Tue, 09 Feb 2010 14:00:00 +0100

SAN DIEGO, Feb. 9, 2010 (GLOBE NEWSWIRE) -- Lithera, Inc. today announced the successful completion of a three-part Phase I clinical trial of LIPO-102 being developed for the treatment of thyroid-related (Graves' Disease) exophthalmos. LIPO-102 is a novel, minimally-invasive, non-ablative approach to localized fat reduction comprising an injectable aqueous combination of salmeterol xinafoate (SX) and fluticasone propionate (FP). This Phase I clinical study, carried out in abdominal adipose tissue serving as a surrogate for orbital adipose tissue, established the safety and pharmacokinetics of LIPO-102 at maximal doses within the 505(b)(2) threshold for a previously FDA-registered drug product. This trial also provided preliminary evidence of efficacy showing dose-related reductions in wais...

MedWorm Message: Get the very latest Swine Flu news via the MedWorm Swine Flu RSS news feed - updated hourly from thousands of authoritative health and news sources.

Providence Health & Services Selects Compuware to Improve Performance and Availability of Clinical Applications

Medical News (via PRIMEZONE) — Tue, 09 Feb 2010 13:57:00 +0100

DETROIT, Feb. 9, 2010 (GLOBE NEWSWIRE) -- Compuware Corporation (Nasdaq:CPWR) today announced that Providence Health & Services Washington Region selected Compuware's EHR Service Delivery Solution — powered by Compuware Vantage — to improve the performance and availability of its clinical applications. With real-time visibility into clinician experience, Providence Health & Services can now proactively resolve performance issues before they impact patient care while also improving system adoption with clinical staff. (Source: Medical News (via PRIMEZONE))

Redpoint Ventures raises $400M for fund

bizjournals.com Health Care:Pharmaceuticals headlines — Tue, 09 Feb 2010 13:55:40 +0100

Redpoint Ventures said Tuesday it has completed raising money for a $400 million fund that will invest in “social and mobile Internet, cloud computing and clean technology spaces.” (FTNT) (Source: bizjournals.com Health Care:Pharmaceuticals headlines)

LPS posts 30% profit jump in 4Q

bizjournals.com Health Care:Pharmaceuticals headlines — Tue, 09 Feb 2010 13:41:57 +0100

Lender Processing Services Inc. reported a 30 percent jump in adjusted net earnings to $79.6 million in the fourth quarter compared with a year earlier largely due to revenue increases and paying down $262 million in debt. (LPS) (Source: bizjournals.com Health Care:Pharmaceuticals headlines)

Aastrom Announces One-for-Eight Reverse Stock Split

Medical News (via PRIMEZONE) — Tue, 09 Feb 2010 13:30:00 +0100

ANN ARBOR, Mich., Feb. 9, 2010 (GLOBE NEWSWIRE) -- Aastrom Biosciences (Nasdaq:ASTM) announced today that its board of directors has approved a one-for-eight reverse stock split of the company's common stock effective on February 18, 2010. The company has filed an amendment to its articles of incorporation to effect the reverse stock split, which was authorized by shareholders at Aastrom's annual meeting in December 2009. Following the reverse stock split, the company expects to have approximately 28.3 million shares of common stock outstanding. (Source: Medical News (via PRIMEZONE))

FDA Move May Bolster Crestor

WSJ.com: Health — Tue, 09 Feb 2010 13:27:39 +0100

The U.S. Food and Drug Administration's approval of AstraZeneca's cholesterol drug Crestor for a new group of patients could open a large new market for the drug. (Source: WSJ.com: Health)

MedWorm Message: Get the very latest Swine Flu news via the MedWorm Swine Flu RSS news feed - updated hourly from thousands of authoritative health and news sources.

Volcano Receives FDA Clearance to Market the Eagle Eye(R) Platinum Digital IVUS Catheter

HSMN NewsFeed — Tue, 09 Feb 2010 13:21:59 +0100

The Eagle Eye(R) Platinum offers significant improvements to Volcano's industry-leading, plug-and-play, all digital IVUS catheter SAN DIEGO, Feb. 9 (HSMN NewsFeed) -- Volcano Corporation (Nasdaq: VOLC), a leading developer and manufacturer of precisio... Devices, Interventional, FDAVolcano, Eagle Eye, IVUS catheter, IVUS imaging (Source: HSMN NewsFeed)

Clinical Study: Biologic Grafts Reduce Postoperative Pain While Creating a Repair as Durable as Synthetic Mesh in Treating Inguinal Hernias

HSMN NewsFeed — Tue, 09 Feb 2010 13:17:35 +0100

BLOOMINGTON, Ind.--(HSMN NewsFeed)--Results from a clinical study led by Luca Ansaloni, M.D., showed that Cook Medicals Biodesign Inguinal Hernia Graft causes less postoperative pain and discomfort while creating a repair as durable as synthetic mesh when... Devices, SurgeryCook Medical, Biodesign, Inguinal Hernia Graft, synthetic mesh, hernioplasty (Source: HSMN NewsFeed)

Ingen Takes Final Steps Towards Increased Export Sales

Medical News (via PRIMEZONE) — Tue, 09 Feb 2010 13:15:00 +0100

YUCAIPA, Calif., Feb. 9, 2010 (GLOBE NEWSWIRE) -- Ingen Technologies, Inc. (Pink Sheets:IGNT), a leading manufacturer of respiratory medical devices, recently announced today that the company was granted approval of the Stage-I audit conducted by BSI America, Inc. on February 5, 2010. (Source: Medical News (via PRIMEZONE))

FlowCardia, Inc. Initiates CENTRAL Study Enrollment

HSMN NewsFeed — Tue, 09 Feb 2010 13:12:37 +0100

Study designed to confirm CROSSER(R) Catheter routinely navigates through the central lumen of SFA chronic total occlusions SUNNYVALE, Calif., Feb. 9 (HSMN NewsFeed) -- FlowCardia, Inc., a worldwide leader in the development of endovascular devices fo... Devices, InterventionalFlowCardia, chronic total occlusions, CENTRAL study, CROSSER Catheter (Source: HSMN NewsFeed)

Xencor Appoints Edgardo Baracchini, Ph.D., to Chief Business Officer

HSMN NewsFeed — Tue, 09 Feb 2010 13:07:54 +0100

MONROVIA, Calif.--(HSMN NewsFeed)--Xencor, Inc., a company using Fc engineering for the discovery and development of next-generation antibodies, announced today the appointment of Edgardo Baracchini, Ph.D., to chief business officer. He brings more than 15... Biopharmaceuticals, PersonnelXencor (Source: HSMN NewsFeed)

MedWorm Message: Get the very latest Swine Flu news via the MedWorm Swine Flu RSS news feed - updated hourly from thousands of authoritative health and news sources.

Valtech Cardio Ltd. Announces Appointment of CEO -- Medtech Veteran Bruce H. KenKnight Joins Valtech Team

HSMN NewsFeed — Tue, 09 Feb 2010 13:04:48 +0100

OR YEHUDA, Israel, Feb. 9 (HSMN NewsFeed) -- Valtech Cardio Ltd. announced today that Bruce H. KenKnight, PhD has joined the Valtech team serving as President and Chief Executive Officer. This announcement comes on the heels of Valtech's recently announ... Devices, Cardiology, PersonnelValtech Cardio (Source: HSMN NewsFeed)

BioSante Pharmaceuticals Appoints Jeffrey W. Winkelman, Ph.D., J.D., Vice President, Oncology Programs

HSMN NewsFeed — Tue, 09 Feb 2010 13:01:11 +0100

LINCOLNSHIRE, Ill.--(HSMN NewsFeed)--BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX ) today announced the appointment of Jeffrey W. Winkelman, Ph.D., J.D. as vice president, oncology programs. His primary responsibilities will be management of BioSantes onc... Biopharmaceuticals, PersonnelBioSante Pharmaceuticals (Source: HSMN NewsFeed)

Penwest Initiates Second Phase IIa Clinical Trial for A0001

Medical News (via PRIMEZONE) — Tue, 09 Feb 2010 13:00:00 +0100

PATTERSON, N.Y., Feb. 9, 2010 (GLOBE NEWSWIRE) -- Penwest Pharmaceuticals Co. (Nasdaq:PPCO) today announced that it has initiated a Phase IIa clinical trial for A0001 in patients with the A3243G mitochondrial DNA point mutation and evidence of impaired mitochondrial function. This point mutation is commonly associated with MELAS syndrome. The study is being conducted at the Newcastle upon Tyne Hospitals in Newcastle, England. Newcastle is a specialist neuroscience center in the United Kingdom that offers comprehensive services for both adults and children suspected of having a rare mitochondrial disorder. (Source: Medical News (via PRIMEZONE))

Adeona Appoints James S. Kuo, M.D., M.B.A., as Chairman, CEO and President

HSMN NewsFeed — Tue, 09 Feb 2010 12:57:38 +0100

Company Intends to Launch and Establish Corporate Partnerships for Its Products ANN ARBOR, MI, Feb 9 --(HSMN NewsFeed)-- Adeona Pharmaceuticals, Inc., (AMEX:AEN ), announced today that it has appointed James S. Kuo, M.D., M.B.A., as Chairman, Chief Exec... Biopharmaceuticals, PersonnelAdeona Pharmaceuticals (Source: HSMN NewsFeed)

The Internet Has More Influence Over Consumer Health Actions than Traditional DTC Channels

Drugs.com - Pharma News — Tue, 09 Feb 2010 12:52:14 +0100

New Report: The Internet Has More Influence Over Consumer Health Actions than Traditional DTC Channels Manhattan Research’s Health Influence Mapping Research Module Helps Marketers Understand the Relative Influence of Various Communication... (Source: Drugs.com - Pharma News)

MedWorm Message: Get the very latest Swine Flu news via the MedWorm Swine Flu RSS news feed - updated hourly from thousands of authoritative health and news sources.

Debiopharm Group Grants an Exclusive Licence for the Development, Manufacture and Commercialisation of Debio 025

HSMN NewsFeed — Tue, 09 Feb 2010 12:52:14 +0100

A Potent, First-in-class Antiviral Agent for the Treatment of Hepatitis C LAUSANNE, Switzerland, February 9 (HSMN NewsFeed) -- Debiopharm Group (Debiopharm), a Swiss-based global biopharmaceutical group of companies with a focus on the development of ... Biopharmaceuticals, LicensingDebiopharm, Novartis, Debio 025, alisporivir, hepatitis C (Source: HSMN NewsFeed)

Chelsea Therapeutics Announces Advancements in Neurogenic Orthostatic Hypotension Registration Program

Medical News (via PRIMEZONE) — Tue, 09 Feb 2010 12:30:00 +0100

CHARLOTTE, N.C., Feb. 9, 2010 (GLOBE NEWSWIRE) -- Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) announced several updates related to its Phase III registration program in neurogenic orthostatic hypotension (NOH), including the selection and preliminary approval by the FDA of Northera(tm) as the U.S. brand name for Droxidopa in this indication. (Source: Medical News (via PRIMEZONE))

Analysts: If Health Reform Fails, Expect More Industry Mergers

Pharma Industry News From Medical News Today — Tue, 09 Feb 2010 12:00:00 +0100

News outlets report on how the fate of the health care overhaul might affect health industry mergers and biotech firms... (Source: Pharma Industry News From Medical News Today)

Stock Alert for Medical International Technology Inc. Issued by StockPreacher

Medical News (via PRIMEZONE) — Tue, 09 Feb 2010 11:50:00 +0100

DALLAS, Feb. 9, 2010 (GLOBE NEWSWIRE) -- StockPreacher.com announces an investment report featuring Medical International Technology Inc. (OTCBB:MDLH). The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision. (Source: Medical News (via PRIMEZONE))

Completely Off Topic – Shaking Hands Spreads More Germs Than Kissing

the international medical market place — Tue, 09 Feb 2010 11:27:31 +0100

(Source: the international medical market place)

MedWorm Message: Get the very latest Swine Flu news via the MedWorm Swine Flu RSS news feed - updated hourly from thousands of authoritative health and news sources.

Access To Private Drugs In Public Hospitals

Pharma Industry News From Medical News Today — Tue, 09 Feb 2010 11:00:00 +0100

Governments are under increasing pressure to provide access to expensive new drugs. Canadian patients who want access to drugs that are not publicly insured are seeking to pay for these drugs within public hospitals, states an article in CMAJ (Canadian Medical Association Journal) This analysis by Colleen M... (Source: Pharma Industry News From Medical News Today)

User Intuitive X-ray Inspection System For Increased Uptime

Pharmaceutical Online News — Tue, 09 Feb 2010 09:23:00 +0100

SmartChek X-ray inspection is an ideal solution for cost-effective inspection of small packaged products to protect your brand. SmartChek delivers the highest detection sensitivities without the complexities typically associated with X-ray inspection with the Mettler-Toledo Safeline hallmark qualities of accuracy, reliability, and ease of operation. (Source: Pharmaceutical Online News)

Medical Breakthroughs With Biotechnology

Pharma Industry News From Medical News Today — Tue, 09 Feb 2010 09:00:00 +0100

A recent article in the Scandia Journal reported that biotechnology is helping to improve our knowledge of many devastating illnesses, and has armed patients and their doctors with exciting new diagnostics and treatments to battle disease... (Source: Pharma Industry News From Medical News Today)

Mettler-Toledo CI-Vision Introduces A White Paper Entitled 'What Machine Vision Can Do For You'

Pharmaceutical Online News — Tue, 09 Feb 2010 08:22:00 +0100

Mettler-Toledo CI-Vision, the leader of vision systems, has produced a white paper outlining the features and benefits of vision systems for food production lines. The document explains how machine vision works and how the technology has improved over time. (Source: Pharmaceutical Online News)

APCER Pharma Announces That LPC Pharma Group To Outsource Pharmacovigilance/Drug Safety To APCER

Pharma Industry News From Medical News Today — Tue, 09 Feb 2010 08:00:00 +0100

APCER Pharma announced that LPC Pharma Group is outsourcing its http://www.pharmacovigilance/drug safety operations to APCER. APCER is a leading global provider of comprehensive drug safety, regulatory services and risk management programs for pharmaceutical, biotechnology, medical device and consumer products companies... (Source: Pharma Industry News From Medical News Today)

MedWorm Message: Get the very latest Swine Flu news via the MedWorm Swine Flu RSS news feed - updated hourly from thousands of authoritative health and news sources.

Leverage Sought In Health Summit

WSJ.com: Health — Tue, 09 Feb 2010 04:56:58 +0100

Republicans ruled out any health legislation that doesn't start from scratch in response to Obama's plans for a bipartisan health summit. (Source: WSJ.com: Health)

First Lady to Fight Childhood Obesity

WSJ.com: Health — Tue, 09 Feb 2010 01:16:03 +0100

Michelle Obama plans to unveil a campaign to fight childhood obesity, a cause that is becoming her top policy priority. (Source: WSJ.com: Health)

Denosumab Demonstrated Superiority Over Zometa(R) in Pivotal Phase 3 Head-to-Head Trial in Prostate Cancer Patients With Bone Metastases

HSMN NewsFeed — Tue, 09 Feb 2010 01:10:30 +0100

Denosumab Trial Met Primary and All Secondary Endpoints by Significantly Delaying Time to First Skeletal Related Event and Significantly Reducing First-and-Subsequent Skeletal Related Events Compared to Zometa Second Phase 3 Advanced Cancer Trial to Demo... Biopharmaceuticals, OncologyAmgen, denosumab, Zometa, zoledronic, bone metastases (Source: HSMN NewsFeed)

Insurer Plays Judge on Cancer Care

WSJ.com: Health — Tue, 09 Feb 2010 00:58:54 +0100

UnitedHealth group sends doctors reports assessing their treatment of breast, lung and colorectal cancer patients. (Source: WSJ.com: Health)

Hearts Actually Can Break

WSJ.com: Health — Tue, 09 Feb 2010 00:31:35 +0100

Broken-heart syndrome mimics a heart attack but is brought on by acute emotion or physical trauma. But patients usually fully recover with no lasting heart damage. (Source: WSJ.com: Health)

MedWorm Message: Get the very latest Swine Flu news via the MedWorm Swine Flu RSS news feed - updated hourly from thousands of authoritative health and news sources.

Sweet: We'll Wait for Our Reward

WSJ.com: Health — Tue, 09 Feb 2010 00:11:40 +0100

New medical findings on blood sugar and the perception of rewards; autism; arthritis; weight loss; ear infections; nicotine patches; diabetes and kidney damage. (Source: WSJ.com: Health)

analytica InnovationArea: Start-ups in the Spotlight

World Pharma News — Tue, 09 Feb 2010 00:00:00 +0100

23-26 March 2010, Munich, Germany. Following its successful premiere in 2008, analytica, the leading trade fair for industrial analysis, laboratory technology and biotechnology, will continue its initiative for new companies again in 2010. (Source: World Pharma News)

Pfizer and Keas Partner to Help Consumers Take a More Active Role in Their Health and Wellness

World Pharma News — Tue, 09 Feb 2010 00:00:00 +0100

Pfizer and Keas announced today they have entered into an alliance to collaborate on the Keas platform to enable Health and Wellness experts to author, sell and distribute personalized online Care Plans directly to patients. (Source: World Pharma News)

FDA Widens Crestor Approval

WSJ.com: Health — Mon, 08 Feb 2010 23:27:18 +0100

The Food and Drug Administration Monday approved wider use of Crestor, AstraZeneca PLC's cholesterol-lowering drug, allowing the company to market the drug to patients who don't have signs of heart disease. (Source: WSJ.com: Health)

Getting Fired by the Family Doctor

WSJ.com: Health — Mon, 08 Feb 2010 23:25:55 +0100

Patients can and frequently do leave doctors they don't see eye to eye with, find inconvenient or can't afford. But doctors must follow strict ethical rules when they want to dismiss a patient. (Source: WSJ.com: Health)

MedWorm Message: Get the very latest Swine Flu news via the MedWorm Swine Flu RSS news feed - updated hourly from thousands of authoritative health and news sources.

Higher Blood Sugar Boosts Perceived Value of Rewards

WSJ.com: Health — Mon, 08 Feb 2010 22:51:26 +0100

New medical findings on blood sugar and the perception of rewards; autism; arthritis; weight loss; ear infections; nicotine patches; diabetes and kidney damage. (Source: WSJ.com: Health)

Becton Dickinson Recalls IV Products

WSJ.com: Health — Mon, 08 Feb 2010 22:46:34 +0100

Becton Dickinson voluntarily recalled some 5.7 million products related to catheters and administering fluids intravenously, saying their use may cause serious injury or death. (Source: WSJ.com: Health)

Alliance to buy Cambridge Laboratories

FT.com - Drugs and Healthcare — Mon, 08 Feb 2010 22:32:16 +0100

The speciality drug company is to buy the bulk of Cambridge Laboratories in a deal valued at between £14m and £16m that will be part-funded with a share placing by Alliance (Source: FT.com - Drugs and Healthcare)

QIAGEN Reports Strong Fourth Quarter and Fiscal 2009 Results

Medical News (via PRIMEZONE) — Mon, 08 Feb 2010 21:00:00 +0100

VENLO, Netherlands, Feb. 8, 2010 (GLOBE NEWSWIRE) -- QIAGEN N.V. (Nasdaq:QGEN) (Frankfurt:QIA) today announced the results of operations for the fourth quarter and the fiscal year ended December 31, 2009. (Source: Medical News (via PRIMEZONE))

Heartland Spine & Specialty Hospital Names Jesse Saucedo Chief Financial Officer

Medical News (via PRIMEZONE) — Mon, 08 Feb 2010 21:00:00 +0100

OVERLAND PARK, Kan., Feb. 8, 2010 (GLOBE NEWSWIRE) -- Heartland Spine & Specialty Hospital, a physician-owned hospital comprised of more than 80 physicians dedicated to improving patient outcomes, has named Jesse Saucedo as the facility's new Chief Financial Officer. (Source: Medical News (via PRIMEZONE))

MedWorm Message: Get the very latest Swine Flu news via the MedWorm Swine Flu RSS news feed - updated hourly from thousands of authoritative health and news sources.

Lupin Receives FDA Approval for Amlodipine/Benazepril Capsules

HSMN NewsFeed — Mon, 08 Feb 2010 20:40:18 +0100

BALTIMORE, Feb. 8 (HSMN NewsFeed) -- Lupin Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration (U.S. FDA) has granted final approval for its Amlodipine/Benazepril 2.5mg/10mg, 5mg/10mg, 5mg/20mg and 10mg/20mg capsules. Commer... Biopharmaceuticals, FDA, GenericsLupin Pharmaceuticals, Amlodipine, Benazepril, Novartis, Lotrel (Source: HSMN NewsFeed)

Sagent Pharmaceuticals Announces FDA Approval of Labetalol Hydrochloride Injection, USP

HSMN NewsFeed — Mon, 08 Feb 2010 20:30:55 +0100

SCHAUMBURG, Ill., Feb. 8 (HSMN NewsFeed) -- Sagent Pharmaceuticals, Inc., a privately held specialty pharmaceutical company, today announced that it has received FDA approval of labetalol hydrochloride (HCl) injection, USP, commonly used to control sever... Biopharmaceuticals, Generics, Cardiology, FDASagent Pharmaceuticals, labetalol, Prometheus Laboratories, Trandate (Source: HSMN NewsFeed)

Banyan Biomarkers Announces New Chief Executive Officer

HSMN NewsFeed — Mon, 08 Feb 2010 20:14:16 +0100

ALACHUA, Fla.--(HSMN NewsFeed)--Banyan Biomarkers, Inc., the leader in developing in vitro diagnostic products to address unmet clinical needs for the detection of traumatic brain injury, announced today the appointment of Jackson Streeter, M.D. as Chief E... Diagnostics, Neurology, PersonnelBanyan Biomarkers, traumatic brain injury (Source: HSMN NewsFeed)

KineMed Broadens Collaboration with Bristol-Myers Squibb

HSMN NewsFeed — Mon, 08 Feb 2010 20:11:20 +0100

EMERYVILLE, Calif.--(HSMN NewsFeed)--KineMed, Inc. a translational and personalized medicine development company, today announced a broadening of its collaboration with Bristol-Myers Squibb Company (NYSE: BMY ) in the area of Alzheimers disease and other ... Biopharmaceuticals, Personalized Medicine, NeurologyKineMed, Bristol-Myers Squibb, Alzheimers disease (Source: HSMN NewsFeed)

Abbott Submits New Automated Ovarian Cancer Test for U.S. Approval

HSMN NewsFeed — Mon, 08 Feb 2010 20:08:55 +0100

Abbott's ARCHITECT human epididymis protein 4 (HE4) assay submitted for 510(k) clearance ABBOTT PARK, Ill., Feb. 8 (HSMN NewsFeed) -- A new diagnostic tool physicians can use to monitor patients for the most common form of ovarian cancer may soon be a... Diagnostics, Oncology, FDAAbbott, ARCHITECT HE4, HE4, ovarian cancer (Source: HSMN NewsFeed)

MedWorm Message: Get the very latest Swine Flu news via the MedWorm Swine Flu RSS news feed - updated hourly from thousands of authoritative health and news sources.

AMAG Pharmaceuticals Provides Feraheme® Safety Update

Drugs.com - Clinical Trials — Mon, 08 Feb 2010 19:45:45 +0100

~ Conference call will be held today at 4:45 p.m. Eastern time ~ LEXINGTON, Mass.--(BUSINESS WIRE)--Feb 5, 2010 - AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG), a biopharmaceutical company focused on the development and commercialization of a... (Source: Drugs.com - Clinical Trials)

Researchers Report Elevated Levels of TÎ²4 Levels Predict Patient Survival in Hepatitis B Virus-related Liver Failure

Drugs.com - Clinical Trials — Mon, 08 Feb 2010 19:41:09 +0100

TÎ²4 – Potential New Therapeutic Agent for Liver Failure BETHESDA, Md.--(BUSINESS WIRE)--Feb 8, 2010 - REGENERX BIOPHARMACEUTICALS, INC. (NYSE Amex:RGN) announced today that researchers have correlated TÎ²4 levels with... (Source: Drugs.com - Clinical Trials)

NOVAVAX Reports Additional Positive Data from Its Trivalent Seasonal Influenza (VLP) Vaccine Clinical Study in Healthy Adults

Drugs.com - Clinical Trials — Mon, 08 Feb 2010 19:31:10 +0100

Data show significant Neuraminidase Inhibition Antibody Titers in VLP vaccine recipients ROCKVILLE, Md., Feb. 8 /PRNewswire-FirstCall/ -- Novavax, Inc. (NASDAQ: NVAX) announced today new data from a clinical study that began in May of... (Source: Drugs.com - Clinical Trials)

Aton Pharma Announces Michael H. Richardson to Head Orphan Drug Division

HSMN NewsFeed — Mon, 08 Feb 2010 18:58:04 +0100

LAWRENCEVILLE, N.J., Feb. 8 (HSMN NewsFeed) -- Aton Pharma, Inc., a diversified specialty pharmaceutical company, announced today that Michael H. Richardson has joined the company as Vice President, Commercial Operations for the newly formed Orphan Drug ... Biopharmaceuticals, PersonnelAton Pharma, Orphan Drug (Source: HSMN NewsFeed)

Neurosurgeon-Scientist Eric C. Holland, MD, PhD to Join Health Enhancement Products Scientific Advisory Board

Medical News (via PRIMEZONE) — Mon, 08 Feb 2010 17:35:00 +0100

SCOTTSDALE, Ariz., Feb. 8, 2010 (GLOBE NEWSWIRE) -- Health Enhancement Products, Inc. (OTCBB:HEPI) today announced Eric C. Holland, MD, PhD, Vice Chair, Translational Research, Department of Neurosurgery; Director, Brain Tumor Center; Emily Tow Jackson Chair in Oncology of Memorial Sloan-Kettering Cancer Center (MSKCC) has joined the Company's Scientific Advisory Board (SAB) effective immediately. (Source: Medical News (via PRIMEZONE))

MedWorm Message: Get the very latest Swine Flu news via the MedWorm Swine Flu RSS news feed - updated hourly from thousands of authoritative health and news sources.

08.02.10: Stock: Consensus

Bayer IR Newsfeed: New on this site — Mon, 08 Feb 2010 17:04:48 +0100

Stock: ConsensusNew: Q4 2009 Consensus estimatesLink to websiteAll changes (Source: Bayer IR Newsfeed: New on this site)

Getting Shingles Vaccine Easier

Drugs.com - Pharma News — Mon, 08 Feb 2010 16:14:54 +0100

[The Columbus Dispatch, Ohio] From Columbus Dispatch (OH) (February 8, 2010) Feb. 8--In theory, people should have scrambled to get the shingles vaccine. The disease is notoriously painful and quite... (Source: Drugs.com - Pharma News)

Becton Dickinson Recalls Catheter, IV Products

WSJ.com: Health — Mon, 08 Feb 2010 15:30:10 +0100

ClearTrial Selected to Provide Methodologies for Accurately Forecasting and Budgeting Clinical Spend and Integrated Financial Controls at CBI Conference

PRWeb: Medical Pharmaceuticals — Mon, 08 Feb 2010 15:15:23 +0100

Two members of the ClearTrial clinical services team to present the critical processes that comprise a more accurate forecast and budget discipline across clinical development departments. (PRWeb Feb 8, 2010) Read the full story at http://www.prweb.com/releases/2010/02/prweb3577044.htm (Source: PRWeb: Medical Pharmaceuticals)

Healthcare Data Solutions Announces Expansion of its Healthcare Customer Solutions Team With Two Key Additions

PRWeb: Medical Pharmaceuticals — Mon, 08 Feb 2010 15:15:23 +0100

Healthcare Data Solutions (http://www.healthcaredatasolutions.com/) (HDS) is pleased to announce that it has hired Lisa Wichman and Sahar Meyer to its expanding staff of healthcare and data experts. Ms. Wichman joins HDS as an Account Manager and will focus on key healthcare markets in the Northeast. Ms. Meyer will lead the AnalyticsPRO Division as the Manager of that group Omaha, NE. (PRWeb Feb 8, 2010) Read the full story at http://www.prweb.com/releases/healthcare-solutions/analytics/prweb3574034.htm (Source: PRWeb: Medical Pharmaceuticals)

MedWorm Message: Get the very latest Swine Flu news via the MedWorm Swine Flu RSS news feed - updated hourly from thousands of authoritative health and news sources.

Mimotopes Awarded Major Peptide Supply Contract by the Queensland Institute of Medical Research in the Search for an Effective Malaria Vaccine

PRWeb: Medical Pharmaceuticals — Mon, 08 Feb 2010 15:15:23 +0100

Mimotopes' PepSets™ to be used to identify novel proteins from the malaria parasite for next generation vaccine development (PRWeb Feb 8, 2010) Read the full story at http://www.prweb.com/releases/2010/02/prweb3564994.htm (Source: PRWeb: Medical Pharmaceuticals)

Global Anti-hypertensive Drugs Market to Exceed $66.2 Billion by 2015, According to a New Report by Global Industry Analysts, Inc.

PRWeb: Medical Pharmaceuticals — Mon, 08 Feb 2010 15:15:23 +0100

GIA announces the release of a comprehensive global report on Anti-hypertensive Drugs markets. The world market for anti-hypertensive drugs is projected to exceed $66.2 billion by the year 2015. This is primarily driven by a rapid rise in the number of patients suffering from high blood pressure, an aging population, and growing diagnosis and treatment rates. Angiotensin II blockers represent the largest class of drug in terms of revenue generation among the five major classes of drugs used for the treatment of hypertension. (PRWeb Feb 8, 2010) Read the full story at http://www.prweb.com/releases/anti_hypertensive_drugs/blood_pressure_medicines/prweb3453394.htm (Source: PRWeb: Medical Pharmaceuticals)

Invida Selects LaVoie Group as Public Relations Agency of Record

PRWeb: Medical Pharmaceuticals — Mon, 08 Feb 2010 15:15:23 +0100

LaVoie Group, a life science-focused strategic communications agency, announced today that it has been selected by Invida Group, the leading provider of healthcare brands and services in Asia Pacific, to develop and execute its corporate communications and public relations program. (PRWeb Feb 8, 2010) Read the full story at http://www.prweb.com/releases/Invida_Group/LaVoie_Group/prweb3573384.htm (Source: PRWeb: Medical Pharmaceuticals)

Florida CFO Sink calls for probe of BofA

bizjournals.com Health Care:Pharmaceuticals headlines — Mon, 08 Feb 2010 15:07:02 +0100

Alex Sink, Florida’s chief financial officer and a former executive at Bank of America, has asked other state officials to investigate potential legal action against the bank. (BAC) (Source: bizjournals.com Health Care:Pharmaceuticals headlines)

AnaptysBio Announces Strategic Collaboration With Merck & Co., Inc.

Pharmaceutical Online News — Mon, 08 Feb 2010 15:00:00 +0100

AnaptysBio, Inc., a privately-held therapeutic antibody platform and product company, today announced a strategic collaboration with Merck, through an affiliate, to develop novel antibody therapeutics to a specified disease target. (Source: Pharmaceutical Online News)

MedWorm Message: Get the very latest Swine Flu news via the MedWorm Swine Flu RSS news feed - updated hourly from thousands of authoritative health and news sources.

ExL Pharma: Bayer Schering Pharma & ExL Pharma on Leading Events for Digital Marketing & PR Professionals

Market Wire - Pharmaceuticals and Biotech — Mon, 08 Feb 2010 15:00:00 +0100

NEW YORK, NY (MARKET WIRE) ExL Pharma's Digital Pharma Europe and European Public Relations & Communications conferences are being held at the Bayer Schering Pharma Headquarters in Berlin on March 29-30, 2010. Both events feature leaders in pharmaceutical, biotechnology and medical device companies, sharing best practices surrounding different forms of communication. (Source: Market Wire - Pharmaceuticals and Biotech)

Carolina Bank posts $1.5M loss

bizjournals.com Health Care:Pharmaceuticals headlines — Mon, 08 Feb 2010 14:59:36 +0100

Carolina Bank posted a net loss of $1.5 million in the fourth quarter, its only quarterly net loss in the year. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)

Shareholders approve Xerox purchase of ACS

bizjournals.com Health Care:Pharmaceuticals headlines — Mon, 08 Feb 2010 14:59:21 +0100

Shareholders of Xerox Corp. and Affiliated Computer Services Inc. Friday approved Xerox’s $6.4 billion purchase of ACS, a Dallas-based company that provides outsourced finance, human resources, information-technology, transaction-processing and customer-support services. (ACS) (XRX) (Source: bizjournals.com Health Care:Pharmaceuticals headlines)

Cell Therapeutics Facing Tougher FDA (CTIC)

BioHealth Investor — Mon, 08 Feb 2010 14:47:10 +0100

Cell Therapeutics, Inc. (NASDAQ: CTIC) is getting clipped on Pixantrone this morning. The company was told by the FDA that there is limited clinical data on its proposed cancer drug, and that there were higher side effects and higher death incidents. Unfortunately, this comes ahead of a panel review date that is set for Wednesday, February 10, 2010. We have late April, on or about April 23, 2010, as the final decision date from the FDA for Pixantrone. Pixantrone is the company’s pending treatment of relapsed and refractory non-Hodgkin’s lymphoma, although this is indicated for those who have seen their disease progress after having received treatment with at least two other therapies. Cell Therapeutics had raised about $30 million in January via securities sales. Pixant...

Park National to combine Eastgate offices

bizjournals.com Health Care:Pharmaceuticals headlines — Mon, 08 Feb 2010 14:01:45 +0100

Park National Bank plans to close two branches in the Eastgate area and combine them at a new facility nearby. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)

MedWorm Message: Get the very latest Swine Flu news via the MedWorm Swine Flu RSS news feed - updated hourly from thousands of authoritative health and news sources.

Pfizer To Sell Viagra In Israel Via Internet

Drugs.com - Pharma News — Mon, 08 Feb 2010 13:54:05 +0100

: This Will Be The First Time A Prescription Drug Is sold on the Internet in Israel, in what the company says is an anti-counterfeiting move. [Globes, Tel Aviv, Israel] From Globes (Tel Aviv)... (Source: Drugs.com - Pharma News)

Addex Pharmaceuticals (CH) - Addex: ADX71943 Demonstrates Analgesic Effects in Pain Models

Drugs.com - Clinical Trials — Mon, 08 Feb 2010 13:53:57 +0100

Geneva, Switzerland, 8 February 2010 - Addex Pharmaceuticals (SIX:ADXN), the allosteric modulation company, announced today that ADX71943 has demonstrated statistically significant analgesic-like effects in three preclinical models of pain. In the... (Source: Drugs.com - Clinical Trials)

BD Announces Worldwide Voluntary Recall of BD Q-Syte(TM) Luer Access Devices and BD Nexiva(TM) Closed IV Catheter Systems

HSMN NewsFeed — Mon, 08 Feb 2010 13:46:49 +0100

FRANKLIN LAKES, N.J., Feb. 8 (HSMN NewsFeed) -- BD (Becton, Dickinson and Company) (NYSE: BDX) has voluntarily executed a product recall of certain lots of BD Q-Syte Luer Access Devices and BD Nexiva Closed IV Catheter Systems. Use of the affected devic... Devices, Product Recall BD, Becton Dickinson, Q-Syte Luer Access, Nexiva Closed IV (Source: HSMN NewsFeed)

New Animal Model for Evaluating Antiviral Agents Against the SARS Virus Indicates Potential Effect of Ampligen(R), an Experimental Therapeutic

Medical News (via PRIMEZONE) — Mon, 08 Feb 2010 13:45:00 +0100

PHILADELPHIA, Feb. 8, 2010 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE Amex:HEB) (the "Company") reported a recent study, published in the December 20th issue of Virology (2009) by a consortium of researchers at Utah State University and the University of North Carolina, on a newly developed animal model of severe acute respiratory disease syndrome (SARS) which, according to the authors, " ... largely mimicked human disease". SARS emerged in 2002 in the Guangdong province of Southern China as a new infectious respiratory disease characterized by influenza-like symptoms with a very high mortality rate. The researchers characterized and adapted a new strain of the SARS virus (SARS-CoV) to mice that was 100% lethal and was associated with the overproduction of cytokines and severe lu...

Neuraltus Pharmaceuticals Names Andrew Gengos President and CEO

HSMN NewsFeed — Mon, 08 Feb 2010 13:39:57 +0100

PALO ALTO, CA, Feb 8 --(HSMN NewsFeed)-- Neuraltus Pharmaceuticals, a privately held biopharmaceutical company dedicated to developing and commercializing products that address critical unmet needs primarily in the treatment of neurodegenerative diseases, ... Biopharmaceuticals, PersonnelNeuraltus Pharmaceuticals (Source: HSMN NewsFeed)

MedWorm Message: Get the very latest Swine Flu news via the MedWorm Swine Flu RSS news feed - updated hourly from thousands of authoritative health and news sources.

Synovis Life Technologies Receives FDA Marketing Clearance for Flow Coupler(R)

HSMN NewsFeed — Mon, 08 Feb 2010 13:37:13 +0100

Microsurgical Device Assesses Blood Flow After Connecting Small Blood Vessels ST. PAUL, Minn.--(HSMN NewsFeed)--Synovis Life Technologies, Inc. (Nasdaq: SYNO ), has received Food and Drug Administration 510(k) marketing clearance for its Flow Coupler&re... Devices, Surgery, FDASynovis Life Technologies, Flow Coupler, Microvascular Anastomotic Coupler (Source: HSMN NewsFeed)

Synovis Life Technologies Receives FDA Marketing Clearance for Flow Coupler®

HSMN NewsFeed — Mon, 08 Feb 2010 13:37:13 +0100

Microsurgical Device Assesses Blood Flow After Connecting Small Blood Vessels ST. PAUL, Minn.--(HSMN NewsFeed)--Synovis Life Technologies, Inc. (Nasdaq: SYNO ), has received Food and Drug Administration 510(k) marketing clearance for its Flow Coupler&re... Devices, FDASynovis Life Technologies, Flow Coupler, Microvascular Anastomotic Coupler (Source: HSMN NewsFeed)

Novavax Terminates Negotiations with ROVI Pharmaceuticals for Influenza Vaccine Collaboration

Drugs.com - Pharma News — Mon, 08 Feb 2010 13:36:37 +0100

ROCKVILLE, Md., Feb. 8 /PRNewswire-FirstCall/ -- Novavax, Inc. (NASDAQ: NVAX) announced today that the company has decided to discontinue negotiations in its pursuit of the previously announced collaboration with ROVI Pharmaceuticals (Madrid: ROVI)... (Source: Drugs.com - Pharma News)

Anthera Pharmaceuticals Announces Agreement With the FDA on a SPA for Planned Phase 3 Varespladib A-002 Study; Daniel K. Spiegelman Joins Board of Directors

HSMN NewsFeed — Mon, 08 Feb 2010 13:33:21 +0100

HAYWARD, Calif., Feb. 8 (HSMN NewsFeed) -- Anthera Pharmaceuticals, Inc., a privately held biopharmaceutical company developing drugs to treat serious diseases associated with inflammation, announced today that it reached an agreement with the U.S. Food ... Biopharmaceuticals, Cardiology, PersonnelAnthera Pharmaceuticals, VISTA-16, Varespladib (Source: HSMN NewsFeed)

Teva Acquires Marketing Rights For Oral Laquinimod In The Nordic And Baltic Regions

Pharmaceutical Online News — Mon, 08 Feb 2010 13:30:00 +0100

Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) and Active Biotech (NASDAQ OMX NORDIC: ACTI) announced today that they have amended the marketing and distribution agreement for oral laquinimod, an investigational treatment for relapsing-remitting multiple sclerosis (RRMS). (Source: Pharmaceutical Online News)

MedWorm Message: Get the very latest Swine Flu news via the MedWorm Swine Flu RSS news feed - updated hourly from thousands of authoritative health and news sources.

Cara Therapeutics Reports Positive Phase II Data for Novel Peripheral Analgesic in Acute Post-Operative Pain

Drugs.com - Clinical Trials — Mon, 08 Feb 2010 13:29:15 +0100

SHELTON, Conn., Feb. 8 /PRNewswire/ -- Cara Therapeutics, Inc. today announced positive data in a Phase II proof-of-concept clinical trial of its peripherally-restricted kappa opioid agonist, CR845. The 46 patient Phase II, multi-center,... (Source: Drugs.com - Clinical Trials)

Stereotaxis Installs First System in Taiwan

HSMN NewsFeed — Mon, 08 Feb 2010 13:28:06 +0100

Expands presence in Asia Pacific to 12 systems ST. LOUIS, Feb. 8 (HSMN NewsFeed) -- Stereotaxis (Nasdaq: STXS) today announced the installation of its first Stereotaxis Magnetic Navigation System in Taiwan at Cheng-Hsin General Hospital (CHMC) located... Devices, CardiologyStereotaxis, Magnetic Navigation System (Source: HSMN NewsFeed)

American Tire to go public

bizjournals.com Health Care:Pharmaceuticals headlines — Mon, 08 Feb 2010 13:26:40 +0100

American Tire Distributors Holdings Inc. has registered with the Securities and Exchange Commission to list its shares on the New York Stock Exchange. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)

Synta Announces STA-9090 Results Demonstrating Potent in vitro and in vivo Activity in AML

Drugs.com - Clinical Trials — Mon, 08 Feb 2010 13:16:47 +0100

- Results presented at hematologic malignancies conference in Singapore - - STA-9090 inhibits WT1, a key driver of leukemias - - STA-9090 currently being studied in two AML clinical trials - LEXINGTON, Mass.--(BUSINESS WIRE)--Feb 8, 2010 - Synta... (Source: Drugs.com - Clinical Trials)

Inovio Biomedical Cervical Cancer Therapeutic Vaccine Generates Dose-Related Immune Response in Clinical Trial

Drugs.com - Clinical Trials — Mon, 08 Feb 2010 13:16:36 +0100

Increased antigen-specific T-cell and antibody responses shown in second, higher dose group SAN DIEGO--(BUSINESS WIRE)--Feb 8, 2010 - Inovio Biomedical Corporation (NYSE Amex: INO), a leader in DNA vaccine design, development and delivery,... (Source: Drugs.com - Clinical Trials)

MedWorm Message: Get the very latest Swine Flu news via the MedWorm Swine Flu RSS news feed - updated hourly from thousands of authoritative health and news sources.

Inovio's Cervical Cancer Therapeutic Vaccine Generates Dose-Related Immune Response

Drugs.com - Clinical Trials — Mon, 08 Feb 2010 13:16:31 +0100

Increased antigen-specific T-cell and antibody responses shown in second, higher dose group SAN DIEGO, CA February 8, 2010 -- Inovio Biomedical Corporation (NYSE Amex: INO), a leader in DNA vaccine design, development and delivery, announced today... (Source: Drugs.com - Clinical Trials)

FDA Drug Safety Communication: Risk of Progressive Multifocal Leukoencephalopathy (PML) with the use of Tysabri (natalizumab)

Drugs.com - Pharma News — Mon, 08 Feb 2010 12:48:21 +0100

Safety Announcement Additional Information for Patients Additional Information for Healthcare Professionals Data Summary Safety Announcement [02-05-2010] The U.S. Food and Drug Administration (FDA) is alerting the public that the... (Source: Drugs.com - Pharma News)

Bristol-Myers Squibb to Stop All Non-Mandated Salary Raises in 2010 to Cut Costs

Drugs.com - Pharma News — Mon, 08 Feb 2010 12:20:59 +0100

From Canadian Press DataFile (February 5, 2010) NEW YORK -- Drugmaker Bristol-Myers Squibb Co. says it is freezing employee salaries for 2010 as it cuts spending and prepares for a drop in sales of its blockbuster blood thinner Plavix. The New... (Source: Drugs.com - Pharma News)

FDA Warns of Brain Risks with Frequent Tysabri Use

Drugs.com - Pharma News — Mon, 08 Feb 2010 12:20:30 +0100

From Associated Press (February 5, 2010) WASHINGTON -- Federal health officials warned doctors Friday that the risk of a deadly brain inflammation linked to the multiple sclerosis treatment Tysabri increases with use of the drug. Tysabri has been... (Source: Drugs.com - Pharma News)

Bristol-Myers Squibb to Stop All Non-Mandated Salary Raises in 2010 to Cut Costs

Drugs.com - Pharma News — Mon, 08 Feb 2010 12:20:30 +0100

MedWorm Message: Get the very latest Swine Flu news via the MedWorm Swine Flu RSS news feed - updated hourly from thousands of authoritative health and news sources.

Even if You're Careful, Drugs Can End up in Water

Drugs.com - Pharma News — Mon, 08 Feb 2010 12:00:34 +0100

From Associated Press (February 7, 2010) PORTLAND, Maine -- The federal government advises throwing most unused or expired medications into the trash instead of down the drain, but they can end up in the water anyway, a study from... (Source: Drugs.com - Pharma News)

Gaining Market Access By Providing Value For Money

Pharma Industry News From Medical News Today — Mon, 08 Feb 2010 12:00:00 +0100

Cost-effectiveness research will become more important as EU responsibility for the pharmaceutical sector moves to the Health and Consumer policy directorate, Lynne Taylor and Peter Mansell report... (Source: Pharma Industry News From Medical News Today)

BIO Joins Stakeholders In Expressing Concerns With Efforts To Restrict Gene Patenting

Pharma Industry News From Medical News Today — Mon, 08 Feb 2010 12:00:00 +0100

The Biotechnology Industry Organization (BIO) released a letter to Health and Human Services Secretary Kathleen Sebelius regarding the potentially harmful recommendations of the Secretary's Advisory Committee on Genetics, Health and Society (SACGHS) in its Report on Gene Patents and Licensing Practices and Their Impact on Patient Access to Genetic Tests... (Source: Pharma Industry News From Medical News Today)

Abbott Submits New Automated Ovarian Cancer Test For U.S. Approval

Pharmaceutical Online News — Mon, 08 Feb 2010 09:53:00 +0100

A new diagnostic tool physicians can use to monitor patients for the most common form of ovarian cancer may soon be available in the United States. (Source: Pharmaceutical Online News)

Birla Kerala Vaidyashala to tie-up with pharma cos for distbution

The Economic Times Healthcare and Biotech News — Mon, 08 Feb 2010 09:41:27 +0100

Birla Kerala Vaidyashala to tie-up with local pharma companies to sell its range of products across the country. (Source: The Economic Times Healthcare and Biotech News)

MedWorm Message: Get the very latest Swine Flu news via the MedWorm Swine Flu RSS news feed - updated hourly from thousands of authoritative health and news sources.

Birla Kerala Vaidyashala to tie-up with pharma cos for distbution

The Economic Times Healthcare and Biotech News — Mon, 08 Feb 2010 09:41:27 +0100

Birla Kerala Vaidyashala to tie-up with local pharma companies to sell its range of products across the country. (Source: The Economic Times Healthcare and Biotech News)

SOHM India Signs Marketing Agreement Adding 75 Branded Generic Pharmaceutical Products For Distribution Across India

Pharmaceutical Online News — Mon, 08 Feb 2010 09:27:00 +0100

SOHM, Inc. (PINKSHEETS: SHMN), a generic pharmaceutical manufacturer that produces and markets generic drugs covering all major treatment categories, announced today that is has signed a marketing agreement adding 75 branded generic pharmaceutical products for distribution across India. (Source: Pharmaceutical Online News)

FIP's Industrial Pharmacy Section Creates Expert Group To Study Tablet Tooling And Sticking

Pharmaceutical Online News — Mon, 08 Feb 2010 09:23:00 +0100

The new IPS Expert Group, created at the 69th International Congress of FIP in Istanbul, Turkey, by Dr. Tom Sam (Schering-Plough), Dr. Gabriele Betz (Industrial Pharmacy Lab, Univ. of Basel), and Mr. Dale Natoli (Natoli Engineering Company), is actively searching for companies interested in contributing to the IPS Expert Group's latest study, Tablet Tooling and Sticking. (Source: Pharmaceutical Online News)

Enhancing Collaboration with the FDA Through MedWatch Plus

PharmaManufacturing.com — Mon, 08 Feb 2010 08:00:58 +0100

This white paper will provide an overview of the benefits and best practices of using the FDA's MedWatch Plus initiative for electronic adverse event reporting within the pharmaceutical industry, as well as other FDA-regulated organizations. (Source: PharmaManufacturing.com)

One-Third of Antimalarial Medicines Sampled in Three African Nations Found to be Substandard in Large-Scale USP-WHO Study

PharmaManufacturing.com — Mon, 08 Feb 2010 08:00:57 +0100

(Source: PharmaManufacturing.com)

MedWorm Message: Get the very latest Swine Flu news via the MedWorm Swine Flu RSS news feed - updated hourly from thousands of authoritative health and news sources.

Health Bill Stall Creates Uncertainty For Drug Makers

Pharma Industry News From Medical News Today — Mon, 08 Feb 2010 08:00:00 +0100

"With the possible demise of health care legislation, getting back to business as usual may not be the best thing for the nation's drug makers," The New York Times reports... (Source: Pharma Industry News From Medical News Today)

Novavax Reports Additional Positive Data From Its Trivalent Seasonal Influenza (VLP) Vaccine Clinical Study In Healthy Adults

Pharmaceutical Online News — Mon, 08 Feb 2010 07:16:00 +0100

Novavax, Inc. (Nasdaq: NVAX ) announced today new data from a clinical study that began in May of 2009 among healthy adults 18 to 49 years of age with Novavax's trivalent seasonal influenza Virus-like Particle (VLP) vaccine. (Source: Pharmaceutical Online News)

Emerging Combination Agent From Merck Will Garner Peak Year Sales Of More Than $250M For The Treatment Of Asthma

Pharmaceutical Online News — Mon, 08 Feb 2010 06:35:00 +0100

Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, following its expected launch this year for the treatment of asthma, Merck's formoterol/mometasone will garner peak year sales of more than $250M in the United States, France, Germany, Italy, Spain and the United Kingdom. (Source: Pharmaceutical Online News)

Lupin Receives FDA Approval For Amlodipine/Benazepril Capsules

Pharmaceutical Online News — Mon, 08 Feb 2010 06:05:00 +0100

Lupin Pharmaceuticals, Inc. announced recently that the U.S. Food and Drug Administration (U.S. FDA) has granted final approval for its Amlodipine/Benazepril 2.5mg/10mg, 5mg/10mg, 5mg/20mg and 10mg/20mg capsules. (Source: Pharmaceutical Online News)

Abbott Submits New Automated Ovarian Cancer Test for U.S. Approval

Abbott.com — Mon, 08 Feb 2010 06:00:00 +0100

(Source: Abbott.com)

MedWorm Message: Get the very latest Swine Flu news via the MedWorm Swine Flu RSS news feed - updated hourly from thousands of authoritative health and news sources.

Montagu set to float BSN Medical

FT.com - Drugs and Healthcare — Mon, 08 Feb 2010 01:44:25 +0100

The German bandages maker has become the latest private equity-owned company to prepare for an initial public offering (Source: FT.com - Drugs and Healthcare)

Pfizer launches e-payment system

FT.com - Drugs and Healthcare — Mon, 08 Feb 2010 01:43:33 +0100

The scheme will link the pharmaceutical group directly with patients in many of the world's fastest-growing economies, a move that could boost use of its high-priced medicines (Source: FT.com - Drugs and Healthcare)

SkillsPlus Announces This Year's GMP Essentials and Trainer Certification Class

Drug Development Technology — Mon, 08 Feb 2010 00:00:00 +0100

SkillsPlus is proud to offer its GMP Essentials and Trainer Certification class again this year. Intended for drug manufacturers, this class reviews the GMPs and how to train others in the regulations using a highly interactive teaching approach. The GMP Essentials and Trainer Certification class will take place 3-7 May 2010 in Philadelphia, PA, US. After this class you will be able to: Explain the intricate details of the GMP regulations Use the philosophical basis of the GMPs to respond to GMP-related questions Demonstrate techniques to present GMP content in memorable ways Design... (Source: Drug Development Technology)

GSK launches new specialist unit to research and develop medicines for rare diseases

World Pharma News — Mon, 08 Feb 2010 00:00:00 +0100

GlaxoSmithKline (GSK) has announced the formation of a new standalone unit specialising in the development and commercialisation of medicines for rare diseases. Over 5,500 rare diseases have been identified(1) of which less than 10% are currently being treated(2), presenting a significant unmet medical need. (Source: World Pharma News)

Obama Seeks Health-Care Summit

WSJ.com: Health — Sun, 07 Feb 2010 22:17:48 +0100

Obama says he has invited Republican and Democratic leaders to discuss health care legislation later this month. (Source: WSJ.com: Health)

MedWorm Message: Get the very latest Swine Flu news via the MedWorm Swine Flu RSS news feed - updated hourly from thousands of authoritative health and news sources.

Twitter Weekly Updates for 2010-02-07

the international medical market place — Sat, 06 Feb 2010 23:00:00 +0100

Invacare – Market Report — In Play (IVC): Briefing.com Business News – MSN Money – http://goo.gl/5BwO # RT @DiabetesMine: New rprt: Casey Johnson's death WAS #diabetes-related http://bit.ly/bD8eyU http://myloc.me/3v0js # Disability Advocates Accept Rahm Emanuel's Apology For 'Retarded' Comment – http://goo.gl/WGfM – (Good – but…) # BBC News – Vegetative state patients can respond to questions – http://goo.gl/KnVD – (see functional MRI) # Medical schools not responding to ghostwriting scandals – http://goo.gl/VmXi – Really hard to believe. Inviting more unwelcome regulation. # NHS going private, USA going public? What next? Politicians need to rethink the role of the private sector in the NHS ̵...

New Restless Leg Syndrome Review for XenoPort (XNPT, GSK)

BioHealth Investor — Sat, 06 Feb 2010 16:46:30 +0100

XenoPort, Inc. (NASDAQ: XNPT) has a big day coming for its GSK1838262/XP13512 (gabapentin enacarbil) next week. The company has a date of February 9 for an FDA Prescription Drug User Fee Act (PDUFA) decision on its Horizant. This is the dated goal for the company’s New Drug Application for Horizant for the treatment of moderate-to-severe primary restless legs syndrome. Horizant is licensed to GlaxoSmithKline (NYSE: GSK) in the United States and several other countries. There is one concern here… The company’s release last week noted that the GaxoSmithKline partnership may be in doubt because Glaxo has noted that it may end research on depression and pain treatments. GSK and XenoPort are discussing the next steps in the development plan for XP13512 in the neuropathic...

Govt plans Rs 2,000 crore fund for pharma research

The Economic Times Healthcare and Biotech News — Sat, 06 Feb 2010 14:59:33 +0100

In an ambitious move to boost drug discovery, the Centre plans to create a fund of Rs 2,000-3,000 crore for pharma research and development, a top government official said here today. (Source: The Economic Times Healthcare and Biotech News)

Govt plans Rs 2,000 crore fund for pharma research

The Economic Times Healthcare and Biotech News — Sat, 06 Feb 2010 14:59:33 +0100

RDPL inks pacts with Rajasthan govt. for generic drug stores

The Economic Times Healthcare and Biotech News — Sat, 06 Feb 2010 09:30:50 +0100

State owned drug manufacturer Rajasthan Drugs and Pharmaceuticals Limited has joined hands with Rajasthan medical department and cooperative department to roll out 105 generic medicine stores across the state within one month. (Source: The Economic Times Healthcare and Biotech News)

MedWorm Message: Get the very latest Swine Flu news via the MedWorm Swine Flu RSS news feed - updated hourly from thousands of authoritative health and news sources.

Launch Of Ipsen's Decapeptyl(R) 6-Month Formulation (LP 22.5 Mg) In France For The Treatment Of Prostate Cancer

Pharma Industry News From Medical News Today — Sat, 06 Feb 2010 09:00:00 +0100

Ipsen (Euronext: FR0010259150; IPN), an innovation-driven global specialty pharmaceutical group and Debiopharm Group (Debiopharm), a Swiss-based global biopharmaceutical group of companies with a focus on the development of prescription drugs that target unmet medical needs, announce the launch by Ipsen in France of Decapeptyl(R) LP 22... (Source: Pharma Industry News From Medical News Today)

Assisted-Suicide Pioneer Stirs Backlash

WSJ.com: Health — Sat, 06 Feb 2010 02:34:10 +0100

The activities of Dignitas, an organization that helps people commit suicide, are creating controversy in a nation with liberal right-to-die laws. (Source: WSJ.com: Health)

NovaBay Pharmaceuticals To Present At The 2010 BIO CEO & Investor Conference

Pharma Industry News From Medical News Today — Sat, 06 Feb 2010 02:00:00 +0100

NovaBay Pharmaceuticals, Inc. (NYSE Amex: NBY), a clinical stage biopharmaceutical company developing first-in-class, anti-infective compounds in the treatment and prevention of antibiotic-resistant infections, today announced that Ron Najafi, Ph.D., Chairman and Chief Executive Officer, will deliver a corporate presentation at the 12th Annual BIO CEO & Investor Conference on Tuesday, Feb... (Source: Pharma Industry News From Medical News Today)

Assisted-Suicide Pioneer Stirs Legal Backlash

WSJ.com: Health — Sat, 06 Feb 2010 00:59:41 +0100

The activities of Dignitas, an organization that helps people commit suicide, are creating controversy in a nation with liberal right-to-die laws. (Source: WSJ.com: Health)

Novus Scientific Receives FDA Clearance for TIGR(TM) Matrix Surgical Mesh - World's 1st Long-Term Resorbable Synthetic Mesh

HSMN NewsFeed — Fri, 05 Feb 2010 22:35:22 +0100

SINGAPORE, UPPSALA, Sweden and CANTON, Mass., Feb. 5 (HSMN NewsFeed) -- Novus Scientific Pte. Ltd today announced that the US Food and Drug Administration (FDA) has given the company 510(k) clearance to market the TIGR Matrix Surgical Mesh, for use in re... Devices, FDANovus Scientific, TIGR Matrix, Surgical Mesh (Source: HSMN NewsFeed)

MedWorm Message: Get the very latest Swine Flu news via the MedWorm Swine Flu RSS news feed - updated hourly from thousands of authoritative health and news sources.

AMAG Fights Back (AMAG)

BioHealth Investor — Fri, 05 Feb 2010 21:39:51 +0100

AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) has had a very tough week, whether it was a market with a bad trading tape or not. The stock’s weakness was after an analyst from a relatively unknown firm called Summer Street downgraded the stock to Neutral from Buy over concerns that Feraheme patients are being hospitalized with severe allergic reaction events. Shares were above $45.00 on Wednesday, yet the stock went as low as $35 today before word that a rebuttal was coming. Then after the close, the company is out defending itself showing that the risks here are very low and may not be any different than previously thought. After the close of trading today, the maker of treatments for anemia and imaging agents provided a safety update on Feraheme®. The company noted, “Sin...

Spread of Swine Flu Slows

WSJ.com: Health — Fri, 05 Feb 2010 20:53:05 +0100

The spread of the H1N1 influenza virus continues to slow across the U.S. (Source: WSJ.com: Health)

FDA Clears Drug Chief of Conflict

WSJ.com: Health — Fri, 05 Feb 2010 20:24:55 +0100

The inspector general of the Department of Health and Human Services has cleared the chief of the drug division at the Food and Drug Administration of allegations of conflict of interest. (Source: WSJ.com: Health)

LEO Pharma's PEP005 Meets Primary Endpoint in Phase III Trial for Pre-Cancerous Skin Condition

Drugs.com - Clinical Trials — Fri, 05 Feb 2010 19:46:33 +0100

BALLERUP, Denmark, Feb. 1 /PRNewswire-USNewswire/ -- LEO Pharma today announced that in a Phase III study, PEP005 (ingenol mebutate) Gel, the company's lead candidate for the topical treatment of actinic (solar) keratosis (AK) or... (Source: Drugs.com - Clinical Trials)

Shire to Present Important Study Findings for Gaucher Disease Treatment and GLD Development Program at the Lysosomal Disease Network (LDN) World Symposium

Drugs.com - Clinical Trials — Fri, 05 Feb 2010 19:25:35 +0100

Data sponsored by the Canadian Fabry Disease Initiative (CFDI) to be presented by Dr. Michael West, Dalhousie University CAMBRIDGE, Mass., Feb. 3 /PRNewswire-FirstCall/ -- Shire plc , the global specialty biopharmaceutical company, today... (Source: Drugs.com - Clinical Trials)

MedWorm Message: Get the very latest Swine Flu news via the MedWorm Swine Flu RSS news feed - updated hourly from thousands of authoritative health and news sources.

Cymbalta Significantly Reduced Chronic Low Back Pain in New Study

Drugs.com - Clinical Trials — Fri, 05 Feb 2010 19:22:01 +0100

INDIANAPOLIS, Feb. 3 /PRNewswire-FirstCall/ -- In a new study, 60 mg of Cymbalta® (duloxetine HCl) taken once daily significantly reduced chronic low back pain, as measured by the Brief Pain Inventory (BPI) average pain rating, compared... (Source: Drugs.com - Clinical Trials)

Protalix Announces Presentation of Phase III Taliglucerase Alfa Data at WORLD Lysosomal Disease Network

Drugs.com - Clinical Trials — Fri, 05 Feb 2010 19:02:05 +0100

CARMIEL, Israel, Feb. 4 /PRNewswire-FirstCall/ -- Protalix Biotherapeutics, Inc. (NYSE- Amex: PLX) today announced that data from its pivotal Phase III trial of taliglucerase alfa in patients with Gaucher disease will be presented at the Annual... (Source: Drugs.com - Clinical Trials)

Tanezumab Demonstrated Analgesic Efficacy Across Three Pain Conditions in Phase Two Studies

Drugs.com - Clinical Trials — Fri, 05 Feb 2010 19:01:42 +0100

SAN ANTONIO, Feb. 4 /PRNewswire-USNewswire/ -- Tanezumab, a humanized monoclonal antibody that targets nerve-growth factor, reduced pain in three common pain conditions, according to the results from three phase two studies presented today in a... (Source: Drugs.com - Clinical Trials)

Researchers Identify Racial Differences in Pain Treatment Outcomes

Drugs.com - Clinical Trials — Fri, 05 Feb 2010 18:58:11 +0100

SAN ANTONIO, Feb. 4 /PRNewswire-USNewswire/ -- Findings from a retrospective analysis of a three-week treatment program for chronic pain revealed African Americans experienced worse outcomes compared to a matched group of Caucasians. The research... (Source: Drugs.com - Clinical Trials)

CREON (Pancrelipase) Delayed-Release Capsules Significantly Improves Fat Absorption in Children with Cystic Fibrosis, Study in Clinical Therapeutics Reports

Drugs.com - Clinical Trials — Fri, 05 Feb 2010 18:44:53 +0100

Data CONFIRMS safe and effective use of CREON® in pediATRIC PAtients - MARIETTA, Ga., Feb. 5 /PRNewswire-FirstCall/ -- Solvay Pharmaceuticals, Inc. announced today that Phase IIIb data published in the January issue of Clinical Therapeutics... (Source: Drugs.com - Clinical Trials)

MedWorm Message: Get the very latest Swine Flu news via the MedWorm Swine Flu RSS news feed - updated hourly from thousands of authoritative health and news sources.

Allow arms to pledge assets: Wockhardt

The Economic Times Healthcare and Biotech News — Fri, 05 Feb 2010 18:41:44 +0100

Troubled pharma firm Wockhardt on Friday argued before the Bombay High Court that none of its subsidiaries should face any restrictions in pledging their assets to borrow. (Source: The Economic Times Healthcare and Biotech News)

4Q profits down at Lake Shore Bancorp

bizjournals.com Health Care:Pharmaceuticals headlines — Fri, 05 Feb 2010 18:25:18 +0100

Fourth quarter net income slipped slightly at Lake Shore Bancorp Inc., falling to $800,000 from $871,000 in the comparable period of 2008. (LSBK) (Source: bizjournals.com Health Care:Pharmaceuticals headlines)

New Publication Supports Safety Profile of RECOTHROM Thrombin, Topical (Recombinant) in Numerous Surgical Settings

Drugs.com - Clinical Trials — Fri, 05 Feb 2010 18:00:45 +0100

Pooled Observations Show Low Rate of Immunogenicity SEATTLE--(BUSINESS WIRE)--Feb 2, 2010 - ZymoGenetics, Inc. (NASDAQ:ZGEN), today announced the publication of pooled safety and immunogenicity observations from eight clinical trials of RECOTHROM in... (Source: Drugs.com - Clinical Trials)

BIO Proposes Second Wave Of Advanced Biofuel Commercialization Policy To Stimulate Job Creation

Pharma Industry News From Medical News Today — Fri, 05 Feb 2010 18:00:00 +0100

Additional Congressional action is needed to follow through on the Obama administration's recently announced initiative to rapidly build an integrated value chain for the bioeconomy, create jobs and kick start economic growth. The Biotechnology Industry Organization (BIO) today released proposed policy options that provide needed incentives to support U.S... (Source: Pharma Industry News From Medical News Today)

Aetna Profit Falls

WSJ.com: Health — Fri, 05 Feb 2010 16:48:40 +0100

Aetna's fourth-quarter earnings fell 15% as the health insurer continued to feel the effects of inadequate pricing that battered its underwriting margins. (Source: WSJ.com: Health)

MedWorm Message: Get the very latest Swine Flu news via the MedWorm Swine Flu RSS news feed - updated hourly from thousands of authoritative health and news sources.

BioMarin Reports Encouraging Preliminary Data on BMN 110 for MPS IVA

Drugs.com - Clinical Trials — Fri, 05 Feb 2010 16:35:54 +0100

Phase III Trial Expected to Start by Q4 2010 or Q1 2011 Conference Call and Webcast to Be Held Today at 5:00 p.m. ET NOVATO, Calif., Feb. 4 /PRNewswire-FirstCall/ -- BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) today announced an update on the Phase... (Source: Drugs.com - Clinical Trials)

Who's Hiring Now

Forbes.com Healthcare News — Fri, 05 Feb 2010 16:21:50 +0100

Leaders of Accenture, Cantor Fitzgerald, Infosys are hiring today. (Source: Forbes.com Healthcare News)

ABC Laboratories Announces Expanded Large Molecule Development Services

Pharmaceutical Online News — Fri, 05 Feb 2010 16:01:00 +0100

Recognizing an increased industry need for outsourced biopharmaceutical services, Analytical Bio-Chemistry Laboratories (ABC) has expanded its offering to include comprehensive support for large molecule development. (Source: Pharmaceutical Online News)

Mississippi AG: Zyprexa Settlement to Offset Budget Cut

Drugs.com - Pharma News — Fri, 05 Feb 2010 15:51:07 +0100

AG: Spend Settlement To Offset Cut [Northeast Mississippi Daily Journal, Tupelo, Miss.] From Northeast Mississippi Daily Journal (Tupelo) (February 5, 2010) Feb. 5--JACKSON -- Attorney General Jim Hood said Thursday he hopes the Legislature will... (Source: Drugs.com - Pharma News)

Diabetes Killed J&J Heiress

Drugs.com - Pharma News — Fri, 05 Feb 2010 15:35:45 +0100

Diabetes Killed Socialite Casey Johnson From UPI Entertainment News (February 4, 2010) The Los Angeles County coroner's office said Thursday socialite Casey Johnson's death was natural and caused by diabetic ketoacidosis. The Johnson &... (Source: Drugs.com - Pharma News)

MedWorm Message: Get the very latest Swine Flu news via the MedWorm Swine Flu RSS news feed - updated hourly from thousands of authoritative health and news sources.

Biomarin To Buy LEAD For $97M, Gives 2010 Outlook

Drugs.com - Pharma News — Fri, 05 Feb 2010 15:19:41 +0100

From Associated Press (February 5, 2010) NOVATO, Calif. -- Enzyme drug maker BioMarin Pharmaceutical said Friday it is buying LEAD Therapeutics, a company testing a drug treatment for rare cancers, in a deal worth up to $97 million. BioMarin... (Source: Drugs.com - Pharma News)

FDA Approves Beech Tree Labs' Influenza IND Application

Drug Development Technology — Fri, 05 Feb 2010 15:19:30 +0100

Beech Tree Labs, Inc., has announced that the FDA has approved its IND for a 180 patient Phase 1/2a clinical evaluation of BTL-TML001, a novel therapeutic agent for treating acute influenza virus infections. In the US outbreaks of seasonal flu are estimated to incur annual costs of more than $12bn, with a mortality rate of over 36,000 people. In the case of a pandemic, estimated annual costs would range from $71bn to $167bn for attack rates of 15%-35% of the population. Beech Tree Labs is a privately held biopharmaceutical company specialising in discovery and early-s... (Source: Drug Development Technology)

Six Key Areas of Learning for Pharmaceutical and Healthcare Marketing in 2010

PRWeb: Medical Pharmaceuticals — Fri, 05 Feb 2010 15:19:24 +0100

AdvanceMarketWoRx Collaborates with 12 Leading Industry Voices in free eBook (PRWeb Feb 3, 2010) Read the full story at http://www.prweb.com/releases/2010/02/prweb3559334.htm (Source: PRWeb: Medical Pharmaceuticals)

Nutricap Labs Lends a Helping Hand to Haiti by Partnering with The American Red Cross

PRWeb: Medical Pharmaceuticals — Fri, 05 Feb 2010 15:19:24 +0100

Nutricap Labs, a leading provider of nutraceutical services such as contract manufacturing, packaging, labeling and order fulfillment, is partnering with The American Red Cross and donating $10,000 toward the organization's Haiti Relief Effort. (PRWeb Feb 3, 2010) Read the full story at http://www.prweb.com/releases/2010/02/prweb3551104.htm (Source: PRWeb: Medical Pharmaceuticals)